Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
March 12, 2025 16:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient...
Alternative Protein Market to Reach USD 589.9 Billion by 2035, Driven by Sustainable Innovations and Rising Consumer Demand | Future Market Insights, Inc.
March 11, 2025 20:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 11, 2025 (GLOBE NEWSWIRE) -- The global alternative protein market, valued at USD 108.1 billion in 2025, is on a trajectory of remarkable expansion, with an anticipated compound...
Dyadic to Attend Multiple Industry Events in March
March 06, 2025 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient...
Steakholder Foods® Announces $1.25 Million Private Placement and $8 Million Equity Line of Credit Funding Mechanism
February 28, 2025 09:00 ET
|
STEAKHOLDER FOODS LTD.
Rehovot, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in alternative proteins and 3D printing technologies, today announced the entry into...
Liberation Labs Closes $50.5 Million Convertible Note
January 30, 2025 08:00 ET
|
Liberation Labs
RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed a convertible note with $31.5 million in new capital, which, combined with $19 million of insider bridge notes raised...
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
November 12, 2024 16:05 ET
|
Dyadic International, Inc.
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
November 04, 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Expands Global Presence with Participation in Key Industry Events
October 09, 2024 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
September 23, 2024 09:50 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient,...
Egg Replacers Market: A Boon for Food Businesses and Sustainability [2024-2029]
August 22, 2024 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The egg replacers market size is poised for significant growth, with a projected value of USD 3.3 billion by 2029, representing a CAGR of 8.0%...